|
|
|
| |
|
 |
|
|
|
|
|
|
|
|
|
|
1 |
Inflammatory Arthritis Secondary to Metastatic Gastric Cancer
|
|
|
|
|
|
|
2 |
Annual Slide Competition Winners (2003) |
|
|
|
|
|
|
3 |
Dieulafoy’s
Lesion, a Rare Cause of Lower
Gastrointestinal Hemorrhage |
|
|
|
|
|
|
4 |
Inverse association between circulating APRIL levels and serological
and clinical disease activity in patients with systemic lupus
erythematosus |
|
|
|
|
|
|
5 |
B lymphocyte stimulator overexpression in patients with systemic lupus
erythematosus: longitudinal observations |
|
|
|
|
|
|
6 |
Inliximab in the Treatment of AA Amyloidosis Secondary to Familial
Mediterranean Fever [ACR - 2002] |
|
|
|
|
|
|
7 |
Infliximab as a Treatment of Familial
Mediterranean Fever |
|
|
|
|
|
|
8 |
Cutaneous Reaction Patterns
Associated with Infliximab Therapy.
[ACR - 2003] |
|
|
|
|
|
|
9 |
New
Treatment of
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME
[EULAR - 2004] |
|
|
|
|
|
|
10 |
Hip Arthroplasty in a 101-Year-Old Patient |
|
|
|
|
|
|
11 |
SPINAL SUBARACHNOID HEMORRHAGE IN
POLYARTERITIS NODOSA [EULAR
- 2005] |
|
|
|
|
|
|
|
12 |
Rituximab treatment for resistant antiphospholipid syndrome |
|
|
|
|
|
|
|
13 |
Anakinra Prevents Symptoms of Familial Cold Autoinflammatory Syndrome
and Raynaud's Disease |
|
|
|
|
|
|
14 |
MAINTENANCE ANAKINRA PREVENTS SYMPTOMS OF FAMILIAL COLD
AUTOINFLAMMATORY SYNDROME AND RAYNAUD'S DISEASE
[EULAR - 2006] |
|
|
|
|
|
|
15 |
Inflammatory Fibromyalgia: Is It Real?
[ACR - 2007] |
|
|
|
|
|
|
16 |
Inflammatory Fibromyalgia: Is It Real?
[EULAR - 2007] |
|
|
|
|
|
|
17 |
Use of Anti-TNF Agents in 15 Rheumatoid Arthritis Patients Undergoing
Total Elbow Arthroplasty. [ACR -
2007] |
|
|
|
|
|
|
18 |
THE USE OF THE TNF ANTAGONIST INFLIXIMAB IN HEART TRANSPLANT
RECIPIENTS: TWO CASE REPORTS
[EULAR - 2007] |
|
|
|
|
|
|
19 |
ADALIMUMAB-INDUCED NONCASEATING GRANULOMA IN THE BONE MARROW OF A
PATIENT BEING TREATED FOR RHEUMATOID ARTHRITIS
[EULAR - 2007] |
|
|
|
|
|
|
20 |
USE OF ANTI-TNF AGENTS IN 15 RHEUMATOID ARTHRITIS PATIENTS UNDERGOING
TOTAL ELBOW ARTHROPLASTY
[EULAR - 2007] |
|
|
|
|
|
|
21 |
The use of the tumour necrosis factor antagonist infliximab in heart
transplant recipients: two case reports. |
|
|
|
|
|
|
22 |
H
Bassiouni, K Zaki, M Elshorbagi, A Mustapha, R Tantawi, H Ali, S
Metyas, DG Arkfeld. Relating bone marrow oedema to hs-CRP in knee
osteoarthritis. [Indian Journal of
Rheumatology - 2010] |
|
|
|
|
|
|
23 |
Metyas SK, Tadros RM, Arkfeld DG. “Adalimumab-Induced Noncaseating
Granuloma in the
Bone Marrow of a Patient being Treated for Rheumatoid Arthritis.”
[Rheumatol Int. 2008]. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical Trials: Principal
Investigator: |
|
|
|
|
|
|
Protocol ML22533: |
|
|
|
An Open Label, Randomized study to evaluate the safety, tolerability
and efficacy of tocilizumab (TCZ) monotherapy or TCZ in combination
with non-biologic DMARDs in patients with active rheumatoid arthritis
who have an inadequate response to current non-biologic or biologic
DMARDs. October 2009 – Present . Sponsor: Roche Pharmaceuticals. |
|
|
|
|
|
|
Protocol A4091043: |
|
|
|
A Multicenter, Randomized, Double-Blind, long term study of the safety
of subcutaneous administration of Tanezumab in patients with
Osteoarthritis of the Knee or Hip. Nov 2009 – Present. Sponsor:
Pfizer, Inc. |
|
|
|
|
|
|
Protocol CNTO148 ART3002: |
|
|
|
A Golimumab Phase 3b, Multicenter, Switch assessment of Subcutaneous
and Intravenous efficacy in Rheumatoid Arthritis Patients who have
Inadequate disease control despite treatment. Sponsor : Centocor Inc |
|
|
|
|
|
|
Sunstone, U3839g: |
|
|
|
A long term study of the safety of Rituxan® in patients with
Rheumatoid Arthritis after an inadequate response to previous anti TNF
therapyJanuary 2007 till Present. Sponsor : Genentech, Inc. and Biogen
Idec, Inc. |
|
|
|
|
|
|
|
|
Powered By: Angels Web
Solutions. net